Pax8 heterozygous mice that displayed mild reduction in TH levels did not live longer compared to wild type mice and featured mild obesity, insulin resistance, increased WAT weight, triglyceride accumulation in skeletal muscle, liver steatosis as well as preponderance to develop liver cancer with age. Here, PAX8 is linked to fatty liver disease.